Nested Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nested Therapeutics, Inc. - overview
Established
2021
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Founded in 2021 by Klaus Hoeflich, Kevan Shokat, and Arvin Dar, and based in Massachusetts, US, Nested Therapeutics, Inc. operates as a biotech company that develops medicines for cancer treatment. In April 2022, Nested Therapeutics, Inc. raised USD 50 million in series A funding led by Goldman Sachs Asset Management, with participation from Avidity Partners, Cowen Investment Management, Foresite Capital, Versant Ventures, and Section 32.
As of 2022, the company is being led by Darrin Miles as its CEO. In April 2022, Nested Therapeutics, Inc. raised USD 50 million in series A funding led by new investor Goldman Sachs Asset Management, with participation from new investors Avidity Partners, Cowen Investment Management, Foresite Capital, Versant Ventures, and Section 32. The firm leverages genomics, computational biophysics, machine learning, and chemical biology to tap mutational clusters and offers a drug discovery platform that creates precision medicines to treat cancers and tumors.
The company intends to use the October 2022 funding to accelerate its pipeline and expand the reach of precision medicine.
Current Investors
Versant Ventures, Goldman Sachs Asset Management, Foresite Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.nestedtx.com
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Nested Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.